Former longtime analyst Jami Rubin resigns from EQRx's CFO role
Jami Rubin is leaving her position as CFO of EQRx, the company disclosed in an SEC filing Monday morning.
Rubin informed EQRx of her decision last Wednesday and will leave the biotech at the end of March. The filing noted Rubin will “contemplate new endeavors” and that the departure isn’t related to “a disagreement with EQRx on any matter relating to EQRx’s operations, policies or practices.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.